Pharming Group N.V. ADR
(PHAR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2006 | 12-2004 | 12-2003 | |
| Sales | 189,305 | 0 | 0 | 0 | 0 |
| Cost of Goods | 23,918 | N/A | N/A | N/A | N/A |
| Gross Profit | 165,387 | N/A | N/A | 1,850 | 2,670 |
| Operating Expenses | 98,089 | 0 | 0 | 370 | 3,990 |
| Operating Income | 68,216 | N/A | N/A | -370 | -3,990 |
| Other Income | -15,935 | 0 | 0 | 0 | 0 |
| Pre-tax Income | 52,281 | 0 | 0 | -370 | -3,990 |
| Income Tax | 11,742 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 40,538 | N/A | N/A | -370 | -3,990 |
| Net Income | $40,538 | $N/A | $N/A | $-370 | $-3,990 |
| EPS Basic Total Ops | 0.65 | N/A | N/A | N/A | N/A |
| EPS Basic Continuous Ops | 0.65 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.60 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | 0.60 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $74,014 | $N/A | $N/A | $320 | $-2,100 |